Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

We show our colours in support of autism awareness
2012-04-11

The Main Building on our Bloemfontein Campus will be illuminated in blue till the end of April to show support for autism awareness.
Photo: René-Jean van der Berg
12 April 2012

The Main Building on our Bloemfontein Campus will be illuminated in blue till the end of April to show our support for autism awareness, together with the rest of the world.

April is Autism Awareness Month and various iconic landmarks worldwide will be lit up in blue to honour those with autism.

Autism is one of only three conditions that are commemorated by the World Health Organisation.

Autism is a neurological condition that can be diagnosed in children as young as three years old. Worldwide one out of every 100 children is diagnosed within the autistic spectrum. This means that in South Africa a child is born with autism every hour and in the Free State some 400 children per year are born with the condition.

“Despite the high prevalence of autism in South Africa, South Africans know very little about it,” says Dr. David Griessel, an autism expert of the UFS’s Department of Paediatrics and Child Health. “Stories and films that attempt to portray autistic characters often create the wrong impression among the public concerning this complex illness. This distorts the reality since every child with autism is unique,” says Dr. Griessel.

He says it is important that all children with signs of autism are referred for evaluation as early intervention can prevent autism from further disrupting normal development.

Therapists and teachers who specialise in autism-specific treatment play an important role in this regard.

“However, there are no well-established services for toddlers in the Free State. Fortunately, there are classes developing in schools such as Lettie Fouché, Willem Postma and Pholoho, as well as in Kroonstad and Welkom. The Free State Autism Association has established a private school that offers a service to seven learners.”

For more information on autism in children or for information on special projects in the Free State, contact Dr. Griessel at +27(0)51 405 53177 or +27(0)51 405 3181.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept